Relevant and even prescient commentary on news, politics and the economy.

Impact of low-value care received by Medicare beneficiaries outside of their health systems

The topic is important as too much resource and funds may be being spent on care with little return. Eighty-one percent of combined low value care was by out of network clinicians of which 90% was by specialists. There is some issues here. If I can find more detail, I will revise this short blurb. […]

Open Thread August 31, 2023 Mixed News Topics

Not Everything We Call Cancer Should Be Called Cancer, rsn.org. The NYPD Denied Our Request for Body Camera Footage of a “Friendly Fire” Killing. Here’s How We Got It Anyway, ProPublica, Mike Hayes. Clarence Thomas officially discloses private jet trips on GOP donor Harlan Crow’s plane, CNN Politics, Ariane de Vogue and Devan Cole. Stay […]

Frozen homeowners means record low inventory, meaning existing home prices have stopped declining

Frozen homeowners mean record low inventory, meaning existing home prices have stopped declining  – by New Deal democrat Before discussing this morning’s reports on existing home prices, let’s start with a look at new listings and total active listings of housing inventory, which are very instructive: This information is not seasonally adjusted, and obviously follows a […]

Viruses of the mind

Guest post as written by Infidel753 and taken from his Blog of the same name. Infidel753: Viruses of the mind, Infidel753 Blog Viruses are the simplest of all living things.  Indeed, it’s questionable whether they should be considered “living” at all.  A virus does not eat, breathe, digest, or perform any other of the organic […]

California Guaranteed Health Care for All Act sets in motion a single-payer healthcare coverage

More detail on California’s Single Payer Bill AB1690. 0223 CA Legal Fact Sheet AB1690 CalCare.pdf, nationalnursesunited.org. Summary Today’s U.S. health care system is a complex, fragmented multi-payer system that still leaves wide gaps of coverage and poses significant issues of affordability. Despite health care spending in the United States far exceeding other high-income, industrialized countries […]

Update on CMS implementation of the Inflation Reduction Act on its 1st anniversary

Passing along information on Biden’s Inflation Reduction Act, one year out, and the impact on the US. Update on CMS implementation of the Inflation Reduction Act on its 1st anniversary, ACA Signups, Charles Gaba via the Centers for Medicare & Medicaid Services (CMS) (note: this press release actually came out on August 16th):

Friendly Fire, Allies tangle over single-payer strategy

California Democrat State Senator Scott Wiener’s (SB770) wants to talk more about single payer which some dispute as even being single payer. Health Care 4 Us (Democrats) join with union nurses in California who champion AB 1690. SB 770, establishes a “working group” to advise the Governor in informal conversations with the federal government about waivers […]

Another win for semaglutide

While I don’t find this surprising, it underscores the power of modern pharmacology. Many drugs deliver only incremental improvement, but semaglutide–like anti-hypertensives and statins–looks transformative for many people. “The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure […]

Voting Yes on CalCare Means No on SB770

A bit of Political Activism Here . . . It appears SB770 is a way to slow the move to Single Payer healthcare in California. AB 1690 needs to be approved. HC4US joins union nurses in California who champion AB 1690, which sets in motion a single-payer health care coverage system for all residents in […]

Public funding for bringing transformative drugs to market

AB: It is a government policy to turn the fruits of its research over to private industry without any strings attached. The 1980 Bayh-Dole Act allows the National Institutes of Health (NIH) and universities housing government-funded scientists to patent and transfer (for royalties, of course) their scientific discoveries, research tools, and drug candidates to private […]